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Abstract
Electrocardiography is a basic diagnostic tool and one that plays a significant role in differentiating many diseases, 
including those involving the right heart. The diagnosis of right ventricular (RV) pathology is difficult due to the complex 
structure and the wide spectrum of haemodynamic disorders resulting from its dysfunction. The use of a standard 
electrocardiogram (ECG) with right-sided leads can be a valuable complement of imaging tests, especially when these 
are not quickly available. Numerous electrocardiographic abnormalities are observed in the course of acute pulmonary 
embolism, chronic pulmonary hypertension, right ventricular myocardial infarction, or arrhythmogenic right ventricular 
cardiomyopathy, and some of these also have prognostic significance. Unfortunately, despite its simplicity and utility, 
ECG is insufficiently sensitive and specific to be the single tool in the recognition of RV pathologies. ECG is a common, 
inexpensive, non-invasive and easily accomplished complementary test, which can be useful in diagnostic algorithm of 
right heart diseases.
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Introduction
Electrocardiography (ECG) has been an irreplaceable 
diagnostic tool for over 100 years in patients reporting 
chest pain, shortness of breath, syncope or palpitations. 
However, when analysing an ECG, do you also remember 
the possibilities of assessing the right ventricle? How 
often do you analyse ride-sided electrocardiogram? Since 
right ventricular (RV) diseases are not infrequent, better 
knowledge of specific electrocardiographic abnormalities in 
the course of these conditions could help the physician to 
avoid confusion and improve a patient’s prognosis. It should 
be emphasised that an ECG examination is characterised 
by insufficient sensitivity and specificity to be used as the 
single diagnostic tool in cases of suspected right heart 
diseases. We discuss below the most critical conditions 
involving RV, and the most common electrocardiographic 
abnormalities that accompany them.
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Significance in evaluation clinical course
Numerous studies have been conducted on the electro-
cardiographic diagnosis of PE. One of them is the study of 
Kukla et al. [4], who observed that ST segment depression 
in leads V4–V6 (p = 0.02), ST segment elevation in aVR 
lead (p = 0.0007), and ST segment elevation  in lead V1 
(p = 0.0002) occur significantly more often in high-risk 
APE than in low-risk APE [4]. Furthermore, researchers 
have shown that the presence of ST elevation in aVR lead 
significantly increases the number of complications during 
hospitalisation (38.3% vs. 12.5%; p < 0.001), and overall 
mortality, compared to people in whom this abnormality 
was not observed (16.5% vs. 6.9%; p = 0.009) [5]. Another 
study by the same group of researchers showed that the 
number of leads with negative T waves (odds ratio [OR] 
1.46; p = 0.001), the presence of RBBB (OR 2.87; p = 0.02), 
and ST segment elevation in V1 (OR 3.99; p = 0.00017), 
and aVR leads (OR 2.49; p = 0.011) are an independent 
prognosis of cardiovascular complications during hospitali-
sation. This study also proved that the sum of the negative 
T-wave amplitudes, the number of leads with negative T 
waves, and the elevation of ST in lead V1, are independent 
predictors of in-hospital mortality [6]. On the other hand, 
the prognosis is the worst in patients with more than five 
leads with negative T waves [7].
The relationship between specific electrocardiographic 
features and the adverse clinical course of APE defined 
as progression to shock, the need for resuscitation, intu-
bation, use of pressure amines, thrombolysis or throm-
bectomy, has also been shown in the recently published 
Acute pulmonary embolism
The pathophysiology of ECG changes in the course of 
acute pulmonary embolism (APE) is complex. In addition 
to excessive pressure overload, damage and ischaemia 
of the myocardium, other more complex mechanisms 
are also suspected, including excessive local adrenergic 
stimulation [1]. So far, numerous ECG abnormalities cau-
sed by APE have been described, and studies are being 
continued in various centres around the world, including 
Poland. One of the first researchers to describe the 
S1Q3T3 pattern, typical of acute pulmonary heart in APE, 
was McGinn and White. Since then, electrocardiographic 
parameters of pulmonary embolism (PE) are better recog-
nised/understood. The most common abnormalities in the 
course of APE include sinus tachycardia, the presence of 
negative T waves in leads V1–V4, depression or elevation 
of ST-T segment in certain lead groups, S1Q3T3 pattern, 
S1S2S3 pattern, right bundle branch block (RBBB), and 
other symptoms as set out in Table 1 (an example of an 
ECG of a patient with APE is shown in Figure 1). It is impor-
tant to emphasise that electrocardiographic findings do 
not prejudge the diagnosis of the disease, and can in fact 
be completely correct even in the course of radiologically 
significant PE. ECG abnormalities are found in 80–90% 
of patients in intermediate and high-risk groups [2]. 
Interestingly, in the course of APE, the longest-lasting 
changes are negative T waves, while other symptoms 
usually disappear within two weeks of initiating proper 
treatment [3].
Table 1. Common electrocardiographic abnormalities in course of acute pulmonary embolism (based on [2])
Standard ECG Tachycardia > 100/min
Atrial arrhythmias
Right axis deviation (dextrogram)
Features of right atrial overload/P pulmonale
Incomplete or complete right bundle branch block (RBBB)
S1Q3T3 pattern (McGinn-White sign) — S wave in lead I, Q wave in lead III with amplitude  
> 0.15 mV, negative T wave in lead III
S1S2S3 pattern — S wave with amplitude > 0.15 mV in leads I–III
QR sign in lead V1 — the Kucher sign
Notched S wave in leads V1–V2
Negative T wave in leads V1–V4 (less often V1–V6)
ST segment depression in leads V4–V6 (less often V1–V6), less often in leads II, III, aVF
ST segment elevation in leads III, aVR, V1
Right axis deviation (dextrogyria)
Low voltage in limb leads
Right ventricular leads V3R–V6R Negative T wave in leads V3R–V6R
RBBB — right bundle branch block
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Figure 1A–D. Electrocardiographic examples of patient with acute pulmonary embolism (A, B) and chronic thromboembolic pulmonary 
hypertension with right ventricular hypertrophy (C, D); records of Piotr Bienias MD, PhD (25 mm /s, 10 mm/mV)
A B
C D
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waves in lead III, and S1Q3T3 pattern (McGinn-White sign). 
The maximum number of points according to the Daniel 
scale is 21; the presence of at least 10 of these suggests 
PH over 50 mm Hg in an angiographic examination with 
a sensitivity of 23.5% and a specificity of 97.7% [11]. In 
a later analysis, Toosi et al. [12] showed that a score of 
3 or more points indicates RV dysfunction (sensitivity 76%, 
specificity 82%), the risk of complications during hospitali-
sation (sensitivity 58%, specificity 60%), and an increased 
risk of death, while a score of below 3 points is associated 
with good short-term prognosis. The high negative predic-
tive value of a result lower than 3 points, which allows to 
predict a positive clinical course with over 90% probability, 
was also confirmed by Kostrubiec et al. [13]. Despite the 
numerous studies conducted, the role of the Daniel ECG 
Scale has still not been clearly determined, and it is not 
included in routine clinical practice.
Another new electrocardiographic model enabling the 
prediction of the presence of RV overload in the course of 
APE was proposed in 2015 by Hariharan et al. [14]. Com-
pared to the Daniel ECG Scale, the researchers presented 
a simplified 10-point TwiST index taking into account the 
occurrence of negative T waves in leads V1–V3 (5 points), 
S waves in lead I (2 points), and tachycardia (3 points). 
A TwiST score of 2 points or below excludes RV overload with 
84% sensitivity [95% confidence interval (CI): 77–90%], 
while a TwiST score greater than or equal to 5 indicates 
RV overload with 93% sensitivity (95% CI: 88–97%) [14].
Fragmented QRS complex
Another QRS abnormality observed in the course of APE 
is QRS fragmentation (fQRS, fragmented QRS). It is sus-
pected that fQRS is caused by ischaemia or the presence 
of a previous scar, which results in abnormal ventricular 
depolarisation. Fragmented QRS was first defined by Das 
et al. [15] in patients with coronary artery disease as the 
presence of at least one R’ wave or notching of the S 
wave or R wave within narrow QRS complex (< 120 ms) of 
different morphologies not meeting the criteria for bundle 
branch block [15]. These criteria are used in ECG analy-
sis of patients with APE, but they are not the only one. In 
a meta-analysis evaluating fQRS’s prognostic value and 
including about 1,200 APE patients, an international team 
of researchers has demonstrated a clear relation between 
the presence of fQRS and the occurrence of cardiogenic 
shock (OR 4.71; p = 0.005), in-hospital death (OR 2.92; 
p < 0.001), as well as death during a two-year follow-up 
period (OR 4.42; p < 0.001) [16]. Therefore, fQRS seems 
to be a potentially useful prognostic marker for APE. Un-
fortunately, due to heterogeneous criteria of fQRS in the 
literature, and significant variability in the assessment 
of the presence of this parameter in ECG among expert 
centres, further analyses are still needed.
meta-analysis of Qaddour et al. [8] covering 39 studies. The 
total number of evaluated patients with APE was 9,198, 
and an independent relationship between the occurrence 
of an adverse clinical course was proven with regard to 
the following changes: tachycardia (OR 4.61; p < 0.001), 
atrial fibrillation on admission (OR 1.78; p < 0.001), 
complete RBBB (OR 2.47; p < 0.001), S1Q3T3 pattern 
(OR 3.89; p < 0.001), ST segment depression in V4–V6 
leads (OR 2.71; p < 0.001), ST segment elevation in lead 
III (OR 3.06; p < 0.001), ST segment elevation in aVR 
lead (OR 3.29; p < 0.001), ST segment elevation in lead 
V1 (OR 5.14; p < 0.001), presence of negative T waves in 
leads V1–V4 and II, III, aVF (OR 2.45; p < 0.001), and qR 
sign in lead V1 (OR 4.65; p < 0.001). This meta-analysis 
also showed that most of the characteristics mentioned 
above are significantly associated with increased in-hospital 
mortality in the course of APE [8].
The importance of ST segment elevation in aVR in pa-
tients with APE must be underlined. Dynamic ST changes 
in this lead were considered nonspecific and without sig-
nificant clinical value for many years, until it was demon-
strated that they could be associated with stenosis of the 
left main coronary artery and/or multivessel disease (in 
the case of the co-existence of significant ST segment de-
pression in ≥ other eight leads). In patients with APE, ST 
segment elevation in aVR indicates an increased risk of 
death and/or deterioration of the general condition with 
the development of shock, as demonstrated in 2013 by 
Zhong-Qun et al. [9] (in those patients ECG — ST segment 
depression in leads I, V4–V6 was registered).
When evaluating ECG in patients with APE, an accurate 
analysis of the morphology of the QRS complex is as impor-
tant as analysis of repolarisation abnormalities. Already in 
the 1960s, Weber and Philips observed the presence of 
a Q wave in lead V1 in patients with APE and its relation 
with an adverse clinical course. In 2003, Kucher et al. aga-
in showed a relation between the occurrence of the qR/ 
/QR sign in lead V1 and an poor prognosis in the course of 
APE (since then this has been called the Kucher sign), and 
Casazza et al. [10] confirmed that the presence of the qR/ 
/QR syndrome in lead V1 is associated with in-hospital mor-
tality in the group of patients with high risk of death (but 
the symptom was only observed in 15.9% of the patients).
Evaluating the probability  
of pulmonary embolism  
and right heart strain
Almost two decades ago, Daniel et al. [11] proposed 
a 21-point ECG scale, which could determine the probability 
of APE and the degree of pulmonary hypertension (PH) in 
its course. The Daniel ECG Scale includes sinus tachycar-
dia, RBBB, incomplete RBBB, negative T waves in leads 
V1–V4, S waves in lead I, Q waves in lead III, negative T 
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QT interval
Recently, exciting results of corrected QT interval in the 
course of APE have also been presented. In comparison 
to a healthy control group, it has been shown that in pa-
tients with APE, the average duration of the QTc interval in 
lead V1 was significantly longer (454.6 ± 44.3 vs. 417.5 
± 31.3 ms; p < 0.001), and the difference between QTc 
duration in lead V1 and lead V6 — greater (34.8 ± 30.5 
vs. –12.5 ± 16.6 ms; p < 0.001). This Korean study also 
showed that QTc difference (V1–V6) greater than or equal 
to 20 ms makes it possible to identify individuals with APE 
with 82.2% sensitivity and 100% specificity [17]. Although 
the authors considered the parameter they identified to 
be an excellent diagnostic tool, it seems that before it is 
widely used, it must be validated by other centres and in 
different racial groups.
Differentiation from acute  
coronary syndrome
Abnormalities presented in ECG in the course of APE may 
raise diagnostic doubts and often require differentiation 
from other emergency conditions. The most important 
practical implication is that APE can clinically and electro-
cardiographically imitate myocardial infarction, both with 
and without ST segment elevation. Depending on the study, 
abnormal changes in the ST-T segment in APE patients, re-
quiring differentiation from acute coronary syndrome (ACS), 
are reported in 40–70% of cases [3, 4, 18]. ST segment 
depression or the occurrence of negative T waves in the 
course of APE seems easy to explain. The presence of the ST 
segment elevations in leads V1–V3/V4 is probably caused by 
RV ischaemia, or may be the result of paradoxical embolism 
to the coronary arteries through a patent foramen ovale or 
atrial septal defect [19]. The aetiology of electrocardiogra-
phic changes imitating ACS with ST segment elevation in the 
inferior leads remains unclear [20]. Electrocardiographic 
differentiation of APE from ACS is still an important rese-
arch goal. Among others, Kosuge et al. [20] noted that the 
coexistence of inverted T waves in leads V1 and III occurs in 
only 1% of patients with ACS, while in the course of APE it is 
found in 88% of cases (p = 0.001) [20].
Right-sided leads
Beyond standard ECG in patients suspected of APE, 
you can also use right-sided V3R–V6R leads in typical 
locations. Unfortunately, due to very limited test results, 
the final diagnostic value of right-sided ECG in patients 
with APE has not been fully established. However, the 
usefulness of right-sided ECG and its advantage over 
a standard ECG exam has been demonstrated in the ini-
tial differentiation of patients suspected of APE, which is 
confirmed by the results obtained by Turkish researchers. 
The most frequently reported abnormalities in V3R–V6R 
leads in patients with APE are negative T waves (64% 
sensitivity) and ST segment elevation (29% sensitivity) 
[21]. It should be emphasised that the final practical va-
lue of this registration requires verification in the course 
of further studies involving large groups of patients. It is 
also worth noting that only repolarisation disorders are 
subject to the analysis of V3R–V6R leads, because the 
voltages, and thus the potential deviations within the QRS 
complex, are too small.
The role of ECG in standards
Despite the undoubted utility of ECG in the diagnostic 
process of patients with APE, the current standards of 
the European Society of Cardiology (ESC) do not include 
standard ECG in the routine diagnostic scheme. Similarly, 
these standards do not indicate the role of ECG in short- and 
long-term risk stratification in patients with confirmed PE.
Pulmonary hypertension
The diagnostic value of ECG in the diagnosis of RV and 
PH hypertrophy is not significant, and it is widely known 
that it must be supplemented by echocardiography and, 
in certain situations, also by invasive measurement during 
right heart catheterisation. The commonly recognised fe-
atures of RV hypertrophy in ECG examinations, presented 
in Table 2 [22], must lead to diagnostics in the direction 
of all forms of PH (an example of an ECG of a patient with 
APE is presented in Figure 1).
It seems that the size of RV hypertrophy is most closely 
correlated with the amplitude of R wave in lead V1; thus the 
higher the amplitude of R wave in lead V1, the higher the 
probability of RV and PH [23]. In one of the latest studies, 
Miura et al. [24] has proposed quick and simplified electro-
cardiographic screening for PH consisting of an accurate 
analysis of the S wave in lead V5 and the occurrence of 
negative T waves in the precordial leads. It has been pro-
ved that the depth of the S wave in V5 lead above 0.42 mV 
(p < 0.001), and the depth of the negative T wave in lead 
V4 above 0.28 mV (p = 0.018), are independent prognostic 
indicators of increased pulmonary arterial pressure by at 
least 25 mm Hg [24].
Importance in evaluating the clinical course
Multi-path analysis conducted by various teams has shown 
that ECG also has potential prognostic value in this group 
of patients. An example of such studies is the analysis of 
Sun et al. [25] who documented that widening the QRS 
complex of at least 120 ms in patients with idiopathic PH 
increases the risk of death 2.5-fold (p < 0.024). Similar 
results were obtained by Rich et al. [26], who also proved 
that in this group of patients QTc prolongation longer than 
or equal to 480 ms is associated with increased mortality 
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[hazard ratio (HR) 3.09, 95% CI: 1, 14–8.38; p < 0.05]. Also, 
it was observed that end-diastolic volume (p <0.001) and 
RV mass (p < 0.05) both increase, and ejection fraction 
decreases (p < 0.05) along with the prolongation of the 
QTc interval [26]. Increased mortality in PH (especially 
arterial) has also been observed in people with V1 lead qR 
syndrome, which occurs in 18–43% of patients according 
to a specific study [27].
Thromboembolic pulmonary hypertension
It is estimated that 0.4–9.1% of people after an APE 
episode may develop chronic thromboembolic pulmonary 
hypertension (CTEPH) after several years [28]. This is the 
only type of PH that can potentially be completely cured, so 
it is vital to detect it early. Clinically, CTEPH is a diagnostic 
challenge, mainly due to the improvement after the APE 
episode, which may dull the patient’s and the attending 
physician’s vigilance (the so-called ‘honeymoon period’ 
usually lasting 6–24 months). The occurrence of right-sided 
heart failure symptoms or intensifying chest discomfort 
in patients with previous APE should be a spur to initiate 
diagnosis. Unfortunately, the symptoms mentioned above 
may occur when more than 40% of the arterial pulmonary 
placenta is obstructed. For this reason, research on the use 
of screening and non-invasive methods that would allow for 
early detection of this dangerous consequence of the EP 
is still ongoing. It is believed that the electrocardiographic 
features of right atrial and right ventricle overload may be 
present in almost 90% of patients with CTEPH [29]. In their 
pioneering work from 2004, Lewczuk et al. [30] described 
the most common abnormalities and their frequency in ECG 
registration in the CTEPH group, i.e. negative T waves in 
leads V1–V5 (in 43%), II, III and aVF (in 32%), P pulmonale 
(in 30%), and deviation of the electrical axis of the heart 
to the right (in 30% of patients). It should be stressed that 
the predictive value of the parameters enumerated above 
proved to be high in the case of CTEPH — both positive 
(> 80%) and negative (< 50%) [30].
In the above mentioned study by Miura et al. [24], of the 
role of ECG in predicting PH in a separate group of patients 
with CTEPH, the most important were the S-wave depth in 
lead V5 (p = 0.027) and the depth of the negative T-wave 
in lead V1 (p < 0.001) [24]. Recently, Klok et al. [31] at-
tempted to develop a diagnostic model excluding CTEPH 
in patients after PE. After taking into account the following 
electrocardiographic parameters: the rSR’/RSr’ syndrome, 
R/S wave ratio above 1 and R amplitude over 0.5 mV in lead 
V1 and electrical axis of the heart over 90°, they showed 
that the absence of the abnormalities mentioned above, 
combined with the correct concentration of N-terminal pro-
-B-type natriuretic peptide (NT-proBNP), allows to exclude 
the disease (> 90% predictive value). The presented model 
was also characterised by 94% sensitivity and 65% specifi-
city in the diagnosis of CTEPH, and the presence of dextro-
gram plays a pivotal role in this algorithm [31].
Right ventricular infarction
Isolated right ventricular infarction (RVI) is rare. Most often, 
RVI accompanies an inferior wall (20–50%) or anterior 
wall of left ventricle infarction (10–15%) [32, 33]. A rarely-
-observed characteristic of RVI is a triad of symptoms, 
i.e. hypotension, jugular vein distention and clear lungs. 
Typically, an RVI diagnosis is confirmed by right-sided 
ECG V3R–V6R, and ST segment elevation at the J point 
greater than or equal to 0.5 mm (or in men < 30 years 
of age ≥ 1 mm). If RVI is suspected, only the ST segment 
elevation has diagnostic value, and its depression, or the 
occurrence of negative T waves, should be treated as an 
abnormal but nonspecific image. Thus, V3R–V6R lead 
assessment also does not allow to recognize RVI without 
ST segment elevation. It should be emphasised that the 
elevation of the ST segment by at least 1 mm in the V4R 
lead is the most sensitive (100%) and most specific (87%) 
electrocardiographic parameter in the diagnosis of RVI. 
Moreover, this is an independent predictor of complicated 
clinical course and in-hospital mortality [34].
RVI cases imitating anterior ischaemia of the left ven-
tricle caused by occlusion of the right coronary artery in its 
proximal segment have also been described in the literatu-
re. In such cases, ST segment elevation is usually greater 
in lead V1 than in lead V2, and it decreases in subsequent 
leads (compared to myocardial infarction due to anterior 
descending branch occlusion). Concomitant diagnosis of 
Table 2. Criteria of right ventricular hypertrophy in electrocardio-
gram (based on [22])
Diagnostic criteria
R wave in lead aVR ≥ 5 mm
R wave in lead V1 ≥ 7 mm
RSR wave in lead V1 — R’ > 10 mm (QRS < 120 ms)
S wave in lead V5 > 10 mm
S wave in lead V6 > 3 mm
R wave in lead V1 + S wave in lead V5 or V6 > 10.5 mm
Other criteria
Dextrogram > + 110 degrees
R wave in lead V1 > S wave in lead V1
S wave in lead I and Q in lead III
Criteria of right atrial hypertrophy
Criterion for presence of right bundle branch block (RBBB)
R wave in lead V1 > 15 mm
Criterion for presence of left bundle branch block (LBBB)
No explicit criterion
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in about half of the patients. However, during more exten-
ded follow-up periods, various ECG abnormalities occur in 
virtually all patients.
Repolarisation abnormalities
The most commonly reported abnormalities are repo-
larisation disorders, while depolarisation abnormalities 
that are more specific to this disease are reported very 
rarely. Typical repolarisation disorders include negative 
T waves in leads V1–V3, and their presence in the ab-
sence of RBBB is considered a typical ARVC sign found 
in 59–83% of patients [38]. In addition, as shown in the 
study by Batchvarov et al. [39], special attention should 
be paid to the T wave in lead V1, which is more negative 
in patients with ARVC than in healthy people (0.21 ± 0.12 
vs. 0.11 ± 0.06 mV; p < 0.0001). The researchers pointed 
out that so far, no detailed analysis of the T wave shape 
had been performed in the group of people suspected of 
having ARVC, and that, in their opinion, this assessment 
could play an important role in the initial diagnosis of 
cardiomyopathy [39].
Depolarisation abnormalities  
and epsilon waves
ECG depolarisation abnormalities found in ARVC include 
an image suggesting incomplete or complete R (not a real 
branch block, but an effect of intramural conduction 
disturbances), wide QRS complex in leads V1–V3 and III 
exceeding 110 ms, the widening of the S wave in leads V1– 
–V3 greater than or equal to 55 ms, and an epsilon wave.
An epsilon wave is a low amplitude wave observed 
in right ventricular precordial leads, typically occurring 
between the end of the QRS complex and the beginning 
of the T wave. It was first described by Fontaine et al. in 
1977 [40], and is considered as a characteristic symptom 
of ARVC, although it occurs in no more than 25% of cases. 
Noticing the epsilon wave in a standard ECG is not easy, 
because in the course of ARVC the QRS complex has va-
rious types of narrowing, especially in its end part and on 
the ascending arm of the S wave (so-called fragmentation 
of the QRS complex). It is said that the fragmentations oc-
curring at the beginning, top, and end of the QRS complex 
should be considered as variants of the epsilon wave. It 
should be noted that sometimes even a few epsilon waves 
can be observed in severe cases of ARVC.
To increase the sensitivity of epsilon wave detection, 
it is recommended to perform ECG with a paper speed of 
50 mm/s and double feature (i.e. 20 mm/mV). You can also 
use the so-called higher leads, i.e. the displacement of the 
V1/V2 electrodes to the III or II intercostal space. Also, by 
using the special lead modification proposed by Fontaine, 
the presence of the epsilon wave can be recorded in up to 
75% of patients. The location of the electrodes according 
to Fontaine should be as follows: the electrode from the 
RVI in such cases is also indicated by the absence of patho-
logical Q-wave in control ECG registration [35].
Right ventricular infarction  
and inferior wall infarction
In patients with RVI on a standard ECG, the most com-
monly observed abnormalities are ischaemic lesions in the 
lower wall area, which is caused by the high incidence of 
infarctions in these areas. The Polish guidelines on elec-
trocardiographic diagnoses emphasise that in the case of 
typical features of the inferior myocardial infarction, a V3R– 
–V6R lead reading should also be performed each time 
to exclude concomitant RVI or RV ischaemia. This implies 
specific pharmacological management (i.e. consideration 
of intravenous fluid therapy, avoidance of vasodilatation 
drugs) and also implies the need for prolonged monitoring, 
because patients with RVI display a significantly increased 
risk of developing various cardiac arrhythmias. Atrioven-
tricular block, severe sinus bradycardia, and ventricular 
fibrillation are the most common arrhythmias in this patient 
group [36].
A large number of scientific studies on RVI or acute RV 
ischaemia come from the era before the age of the wide-
spread use of cardiac troponins in diagnostics and before 
the era of invasive coronary revascularisation, which is 
an essential element of ACS therapy, and which results in 
better diagnosis of heart attacks and better clinical cour-
se. The consequences also include different dynamics and 
the evolution of myocardial infarction symptoms, including 
RVI in ECG registration, and another prognostic value of 
ECG changes that cannot be translated into current times.
Arrhytmogenic right 
ventricular cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy (ARVC) 
is a rare, genetically determined disease in which healthy 
myocardial tissue is replaced by fibrous and adipose tissue. 
The disease mainly affects RV, but it can also involve the left 
ventricle. Its incidence is 1:2,000–1:5,000 births and it is 
one of the most common causes of sudden cardiac death 
in young people and athletes. Diagnosing ARVC is not easy. 
Due to RV geometry, the assessment of its morphology 
and function in transthoracic echocardiography is limited. 
In turn, magnetic resonance imaging, which until recently 
was an indisputable diagnostic criterion, has a high risk of 
false-positive diagnoses. The currently used criteria for the 
diagnosis of ARVC developed by the appropriate working 
team take into account the co-occurrence of structural, 
functional, and histological changes in the heart, abnor-
malities in ECG recordings, and Holter monitoring, as well 
as family medical history [37]. Characteristic ECG changes 
play a key role in the diagnostic algorithm, although they 
are rare at the beginning of the disease — they occur only 
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left upper limb (yellow) should be placed at the height of 
the xiphoid process, the electrode from the right upper limb 
(red) at the level of the manubrium, and the electrode from 
the left lower limb (green) at the location of the precordial 
electrode V4 or V5. 
The presence of the epsilon wave is not an independent 
risk factor for sudden death or arrhythmias, but it indicates 
a large extent of the disease process. It should also be no-
ted that it can sometimes be observed in RVI, myocarditis, 
and sarcoidosis [41].
In recent years, ARVC researchers have also been in-
terested in aVR lead. In the absence of typical [42] elec-
trocardiographic features of ARVC as set out in Table 3, 
changes in this lead may facilitate a proper diagnosis. In 
the case of patients with cardiomyopathy in aVR lead, the 
following changes can often be observed: deep Q waves 
(≥ 0.3 mV) due to the presence of an electroanatomic scar, 
low R wave amplitude (≤ 0.2 mV) resulting from myocardial 
atrophy, and negative T waves (43). The above abnormali-
ties are characterised by high sensitivity (97%), moderate 
specificity (81%), and, more importantly, high negative pre-
dictive value reaching 99%. The positive predictive value 
of the above parameters is low (30%). An epsilon wave is 
rarely observed in aVR lead (in approximately 5% of cases) 
[44]. It is often associated with heart failure (p = 0.04) and 
increased mortality (p = 0.03) [45].
Ventricular late potentials
It should be remembered that signal-averaged electrocar-
diography is still a high-value method in the diagnosis of 
ARVC — the presence of late potentials with specific cha-
racteristics in this group of patients has a high diagnostic 
value, but the availability of the examination is significantly 
limited [44].
Conclusion
A comprehensive assessment of the right ventricle of the 
heart is an exacting challenge which requires great meti-
culousness on the part of physicians. Electrocardiography 
remains a critical component of this diagnosis, in addition 
to in-depth medical history, physical examination, and 
imaging. An analysis of standard ECG along with right-sided 
Table 3. Typical electrocardiographic abnormalities in course of 
arrhythmogenic right ventricular cardiomyopathy (based on [42])
Repolarisation abnormalities
Inverted T wave in leads V1–V3 in patients > 14 years of age 
without RBBB
Inverted T wave in leads V1–V2 in patients > 14 years of age 
without RBBB or in leads V4–V6
Inverted T wave in leads V1–V4 in patients > 14 years of age 
in the presence of RBBB
Depolarisation abnormalities
Epsilon wave in leads V1–V3
Duration of QRS complexes in precordial leads V1–V3 and III 
(> 110 ms)
Widening of S wave in leads V1–V3 ≥ 55 ms in patients with-
out RBBB (measurement taken from the nadir of S wave to 
the end of the QRS complex, including R waves in leads V1, 
V2 or V3)
Rhythm and conduction disorders
Complete or incomplete RBBB 
Nonsustained or sustained ventricular tachycardia of left bun-
dle-branch morphology with superior axis (negative or indeter-
minate QRS in leads II, III, and aVF and positive in lead aVL)
Nonsustained or sustained ventricular tachycardia with right 
ventricular outflow tract configuration or LBBB morphology 
with inferior axis (positive QRS in leads II, III, and aVF and ne-
gative in lead aVL)
RBBB — right bundle branch block; LBBB — left bundle branch block
ECG may be of crucial importance in making an accurate 
diagnosis as well as assessing prognosis.
We must say again that an ECG registration is charac-
terised by insufficient sensitivity and specificity to be the 
one and only diagnostic tool in the case of diseases with 
a predominant RV involvement. Ongoing research, which 
seeks to broaden the knowledge of ECG changes in the co-
urse of diseases with RV involvement, gives hope for better 
use in future of this widely available diagnostic method.
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Streszczenie
Elektrokardiografia (EKG) odgrywa znaczącą rolę w różnicowaniu wielu chorób, w tym przebiegających z zajęciem pra-
wego serca. Rozpoznanie patologii prawej komory (RV) bywa trudne ze względu na złożoną budowę oraz szerokie spek-
trum zaburzeń hemodynamicznych wynikających z jej dysfunkcji. Standardowy zapis EKG czynności serca uzupełniony 
o rejestrację odprowadzeń prawokomorowych może być w tym przypadku cennym uzupełnieniem badań obrazowych, 
zwłaszcza gdy te nie są szybko dostępne.
W przebiegu ostrej zatorowości płucnej, nadciśnienia płucnego, zawału prawej komory czy arytmogennej kardiomopatii 
prawokomorowej obserwuje się liczne nieprawidłowości elektrokardiograficzne pomocne w diagnostyce, a część z nich 
ma znaczenie prognostyczne. Niestety, mimo swojej prostoty i użyteczności EKG cechuje się niedostateczną czułością 
i swoistością, by mógł stanowić pojedyncze narzędzie diagnostyczne w wykrywaniu nieprawidłowości RV. Elektrokar-
diografia to powszechne, tanie, nieinwazyjne i łatwe do wykonania badanie uzupełniające, które może mieć istotne 
znaczenie w algorytmie diagnostycznym różnych chorób przebiegających z zajęciem RV.
Słowa kluczowe: elektrokardiografia, zatorowość płucna, nadciśnienie płucne, zawał prawej komory, arytmogenna 
kardiomiopatia prawej komory
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